Viela Bio (United States)
How to Contact Viela Bio
Phone
1-240-558-2232About Viela Bio
Viela Bio, acquired by Horizon Therapeutics (now Amgen), developed treatments for autoimmune and inflammatory diseases. The company created Uplizna (inebilizumab), an anti-CD19 therapy for neuromyelitis optica spectrum disorder (NMOSD). Viela’s innovative immunology approach continues advancing treatments for rare autoimmune conditions.
Medications
Medications Manufactured by Viela Bio
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
Report to
👉
(UK)
👉
(US)
